Recent News
Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio
As a leader in engineering human enzymes to address significant unmet medical needs in rare genetic diseases and cancer, Aeglea BioTherapeutics is committed to using… Continue Reading →
International Next-Generation Immunotherapy Developer Partners with The Chase Group to Build New Executive Team
The Chase Group is pleased to announce our recent partnership and executive search engagement with the international biopharmaceutical company, Immunovative Therapies, Ltd. (ITL), currently headquartered… Continue Reading →
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor… Continue Reading →
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with… Continue Reading →Continued growth at Genmab leads back to The Chase Group in search for a Director/Senior Director, Drug Safety Physician
As Genmab continues its expansion into full product development, the need for high caliber talent is essential in executing their mission to create and develop… Continue Reading →
Esteemed Allen Institute Partners with The Chase Group for Cutting-Edge Executive Search
The Chase Group is pleased to announce our recent partnership and executive search engagement with the highly-respected Allen Institute in Seattle, Washington. Devoted to unlocking… Continue Reading →
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board… Continue Reading →Genmab Partners with The Chase Group to Build Their Translational Research Team
Genmab has once again retained The Chase Group with a new request to assist with the continued growth of their Translational Research team. The Chase… Continue Reading →